Dipyridamole inhibits cobalt chloride-induced osteopontin expression in NRK52E cells

Tso Hsiao Chen, Chia Fang Chang, Shu Chuan Yu, Jiueng Chueng Wang, Cheng Hsien Chen, Paul Chan, Horng M. Lee

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Osteopontin plays a pivotal role in the progression of interstitial fibrosis in renal ischemia. In the present study, rat renal tubular NRK52E cells treated with hypoxia mimetic cobalt chloride (CoCl2) increased osteopontin production, and are associated with increased phosphorylation of Akt/PKB (protein kinase B) and p38 mitogen-activated protein kinase (p38MAPK). Furthermore, pretreatment of cells with l-N-acetylcysteine (an antioxidant) inhibited CoCl2-stimulated osteopontin protein expression and p38MAPK phosphorylation, but not Akt/PKB phosphorylation. Pretreatment of cells with anti-inflammatory agents celecoxib, tanshinone IIA, and dipyridamole inhibited CoCl2-induced osteopontin production paralleled by heme oxygenase-1 (HO-1) induction. Pretreatment of cells with tin protoporphyrin (a HO-1 inhibitor) or hemoglobin (a carbon monoxide scavenging agent) reversed dipyridamole inhibition of osteopontin expression. Moreover, transfection of HO-1 small interfering RNA (siRNA) reduced dipyridamole-stimulated mitogen-activated protein kinase phosphatase-1 (MKP-1) phosphorylation. Conversely, MKP-1 knockdown reversed dipyridamole inhibition of osteopontin expression. Taken together, these data suggest that dipyridamole may inhibit CoCl2-induced osteopontin expression through HO-1 induction. Increased HO-1 may catalyze the conversion of heme into carbon monoxide, in turn carbon monoxide activates MKP-1. MKP-1 activation inhibits the p38MAPK signaling pathway that mediates CoCl2-induced osteopontin production.

Original languageEnglish
Pages (from-to)10-18
Number of pages9
JournalEuropean Journal of Pharmacology
Volume613
Issue number1-3
DOIs
Publication statusPublished - Jun 24 2009

Fingerprint

Osteopontin
Dipyridamole
Heme Oxygenase-1
Mitogen-Activated Protein Kinase Phosphatases
Dual Specificity Phosphatase 1
p38 Mitogen-Activated Protein Kinases
Carbon Monoxide
Phosphorylation
Celecoxib
Kidney
Proto-Oncogene Proteins c-akt
cobaltous chloride
Acetylcysteine
Heme
Small Interfering RNA
Transfection
Hemoglobins
Fibrosis
Anti-Inflammatory Agents
Ischemia

Keywords

  • Dipyridamole
  • Heme oxygenase-1
  • NRK52E tubular cell
  • Osteopontin

ASJC Scopus subject areas

  • Pharmacology

Cite this

Dipyridamole inhibits cobalt chloride-induced osteopontin expression in NRK52E cells. / Chen, Tso Hsiao; Chang, Chia Fang; Yu, Shu Chuan; Wang, Jiueng Chueng; Chen, Cheng Hsien; Chan, Paul; Lee, Horng M.

In: European Journal of Pharmacology, Vol. 613, No. 1-3, 24.06.2009, p. 10-18.

Research output: Contribution to journalArticle

@article{f3856b5553394386bd695522b882e478,
title = "Dipyridamole inhibits cobalt chloride-induced osteopontin expression in NRK52E cells",
abstract = "Osteopontin plays a pivotal role in the progression of interstitial fibrosis in renal ischemia. In the present study, rat renal tubular NRK52E cells treated with hypoxia mimetic cobalt chloride (CoCl2) increased osteopontin production, and are associated with increased phosphorylation of Akt/PKB (protein kinase B) and p38 mitogen-activated protein kinase (p38MAPK). Furthermore, pretreatment of cells with l-N-acetylcysteine (an antioxidant) inhibited CoCl2-stimulated osteopontin protein expression and p38MAPK phosphorylation, but not Akt/PKB phosphorylation. Pretreatment of cells with anti-inflammatory agents celecoxib, tanshinone IIA, and dipyridamole inhibited CoCl2-induced osteopontin production paralleled by heme oxygenase-1 (HO-1) induction. Pretreatment of cells with tin protoporphyrin (a HO-1 inhibitor) or hemoglobin (a carbon monoxide scavenging agent) reversed dipyridamole inhibition of osteopontin expression. Moreover, transfection of HO-1 small interfering RNA (siRNA) reduced dipyridamole-stimulated mitogen-activated protein kinase phosphatase-1 (MKP-1) phosphorylation. Conversely, MKP-1 knockdown reversed dipyridamole inhibition of osteopontin expression. Taken together, these data suggest that dipyridamole may inhibit CoCl2-induced osteopontin expression through HO-1 induction. Increased HO-1 may catalyze the conversion of heme into carbon monoxide, in turn carbon monoxide activates MKP-1. MKP-1 activation inhibits the p38MAPK signaling pathway that mediates CoCl2-induced osteopontin production.",
keywords = "Dipyridamole, Heme oxygenase-1, NRK52E tubular cell, Osteopontin",
author = "Chen, {Tso Hsiao} and Chang, {Chia Fang} and Yu, {Shu Chuan} and Wang, {Jiueng Chueng} and Chen, {Cheng Hsien} and Paul Chan and Lee, {Horng M.}",
year = "2009",
month = "6",
day = "24",
doi = "10.1016/j.ejphar.2009.03.063",
language = "English",
volume = "613",
pages = "10--18",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Dipyridamole inhibits cobalt chloride-induced osteopontin expression in NRK52E cells

AU - Chen, Tso Hsiao

AU - Chang, Chia Fang

AU - Yu, Shu Chuan

AU - Wang, Jiueng Chueng

AU - Chen, Cheng Hsien

AU - Chan, Paul

AU - Lee, Horng M.

PY - 2009/6/24

Y1 - 2009/6/24

N2 - Osteopontin plays a pivotal role in the progression of interstitial fibrosis in renal ischemia. In the present study, rat renal tubular NRK52E cells treated with hypoxia mimetic cobalt chloride (CoCl2) increased osteopontin production, and are associated with increased phosphorylation of Akt/PKB (protein kinase B) and p38 mitogen-activated protein kinase (p38MAPK). Furthermore, pretreatment of cells with l-N-acetylcysteine (an antioxidant) inhibited CoCl2-stimulated osteopontin protein expression and p38MAPK phosphorylation, but not Akt/PKB phosphorylation. Pretreatment of cells with anti-inflammatory agents celecoxib, tanshinone IIA, and dipyridamole inhibited CoCl2-induced osteopontin production paralleled by heme oxygenase-1 (HO-1) induction. Pretreatment of cells with tin protoporphyrin (a HO-1 inhibitor) or hemoglobin (a carbon monoxide scavenging agent) reversed dipyridamole inhibition of osteopontin expression. Moreover, transfection of HO-1 small interfering RNA (siRNA) reduced dipyridamole-stimulated mitogen-activated protein kinase phosphatase-1 (MKP-1) phosphorylation. Conversely, MKP-1 knockdown reversed dipyridamole inhibition of osteopontin expression. Taken together, these data suggest that dipyridamole may inhibit CoCl2-induced osteopontin expression through HO-1 induction. Increased HO-1 may catalyze the conversion of heme into carbon monoxide, in turn carbon monoxide activates MKP-1. MKP-1 activation inhibits the p38MAPK signaling pathway that mediates CoCl2-induced osteopontin production.

AB - Osteopontin plays a pivotal role in the progression of interstitial fibrosis in renal ischemia. In the present study, rat renal tubular NRK52E cells treated with hypoxia mimetic cobalt chloride (CoCl2) increased osteopontin production, and are associated with increased phosphorylation of Akt/PKB (protein kinase B) and p38 mitogen-activated protein kinase (p38MAPK). Furthermore, pretreatment of cells with l-N-acetylcysteine (an antioxidant) inhibited CoCl2-stimulated osteopontin protein expression and p38MAPK phosphorylation, but not Akt/PKB phosphorylation. Pretreatment of cells with anti-inflammatory agents celecoxib, tanshinone IIA, and dipyridamole inhibited CoCl2-induced osteopontin production paralleled by heme oxygenase-1 (HO-1) induction. Pretreatment of cells with tin protoporphyrin (a HO-1 inhibitor) or hemoglobin (a carbon monoxide scavenging agent) reversed dipyridamole inhibition of osteopontin expression. Moreover, transfection of HO-1 small interfering RNA (siRNA) reduced dipyridamole-stimulated mitogen-activated protein kinase phosphatase-1 (MKP-1) phosphorylation. Conversely, MKP-1 knockdown reversed dipyridamole inhibition of osteopontin expression. Taken together, these data suggest that dipyridamole may inhibit CoCl2-induced osteopontin expression through HO-1 induction. Increased HO-1 may catalyze the conversion of heme into carbon monoxide, in turn carbon monoxide activates MKP-1. MKP-1 activation inhibits the p38MAPK signaling pathway that mediates CoCl2-induced osteopontin production.

KW - Dipyridamole

KW - Heme oxygenase-1

KW - NRK52E tubular cell

KW - Osteopontin

UR - http://www.scopus.com/inward/record.url?scp=65749094824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65749094824&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2009.03.063

DO - 10.1016/j.ejphar.2009.03.063

M3 - Article

C2 - 19356721

AN - SCOPUS:65749094824

VL - 613

SP - 10

EP - 18

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -